InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,376.43
(
0.80%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Bxofscidad

Send PM Follow Ignore
Followers 0
Posts 232
Boards Moderated 0
Alias Born 06/13/2010

Bxofscidad

Re: lt56 post# 2560

Friday, 10/15/2010 4:47:35 PM

Friday, October 15, 2010 4:47:35 PM

Post# of 80490


One correction


SUCCEED trial "WILL NOT FAIL".



1- Drug is too safe

2- No new Sarcoma druig has been approved for over 20 years

3- Phase 1 and Phase 11 results tell us that the drug works well enough to be approved.

4- The FDA knows that there are thousands of patients who are in need of a drug to help with their sarcoma.

5- Merck has the experience to navigate the drug to an approval.



Barry
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up